PROVENGE

PROVENGE helps you fight prostate cancer using your own immune system

PROVENGE is the first approved immunotherapy for advanced prostate cancer. KCUC is now an exclusive provider.

Key Discussion Points

  • In a clinical study, PROVENGE helped men live longer. In this study, more men treated with PROVENGE were alive at 3 years than men who were not treated.
  • Most side effects are generally mild to moderate and last only a day or two. The most common side effects are chills, fatigue, fever, back pain, nausea, joint ache, and headache.
  • PROVENGE therapy can be completed in about a month with only 3 infusions.
American College of Radiology Radiation Oncology Accredited Facility
Accredited by the premier credentialing body for radiation oncology, ACR (The American College of Radiology).